ATM and Chk2-dependent phosphorylation of MDMX contribute to p53 activation after DNA damage
Open accessAbstract
The p53 tumor suppressor is activated after DNA damage to maintain genomic stability and prevent transformation. Rapid activation of p53 by ionizing radiation is dependent on signaling by the ATM kinase. MDM2 and MDMX are important p53 regulators and logical targets for stress signals. We found that DNA damage induces ATM-dependent phosphorylation and degradation of MDMX. Phosphorylated MDMX is selectively bound and degraded by MDM2 preceding p53 accumulation and activation. Reduction of MDMX level by RNAi enhances p53 response to DNA damage. Loss of ATM prevents MDMX degradation and p53 stabilization after DNA damage. Phosphorylation of MDMX on S342, S367, and S403 were detected by mass spectrometric analysis, with the first two sites confirmed by phosphopeptide-specific antibodies. Mutation of MDMX on S342, S367, and S403 each confers partial resistance to MDM2-mediated ubiquitination and degradation. Phosphorylation of S342 and S367 in vivo require the Chk2 kinase. Chk2 also stimulates MDMX ubiquitination and degradation by MDM2. Therefore, the E3 ligase activity of MDM2 is redirected to MDMX after DNA damage and contributes to p53 activation.
AI snapshot
Written from the paper’s full text.
TL;DR
DNA damage induces ATM- and Chk2-dependent phosphorylation of MDMX at C-terminal serines, promoting MDM2 binding, ubiquitination, and degradation of MDMX, which contributes to p53 activation. Reducing MDMX by RNAi enhances p53 response and cell-cycle arrest after ionizing radiation.
Key findings
- DNA damage induces MDMX phosphorylation and degradation; phosphorylated MDMX is selectively bound and degraded by MDM2, and ATM-deficient fibroblasts fail to induce MDMX mobility shift/degradation after radiation.
- Mass spectrometry mapped MDMX phosphorylation on S161 (post-IR), S342 (pre- and post-IR), S367 (pre- and post-IR), S391 (post-IR), and S403 (post-IR), with approximately 77% peptide coverage; S342 and S367 were confirmed by phosphopeptide-specific antibodies.
- Mutation of S342, S367, and S403 each reduced MDM2-mediated polyubiquitination, with S367 having the most significant effect; the triple alanine mutant MDMX-3A was resistant to degradation after DNA damage and inhibited p53 activation more efficiently than wild-type MDMX.
- Chk2 was required in vivo for S342 and S367 phosphorylation after irradiation; Chk2-null HCT116 cells showed less efficient MDMX degradation and reduced p53 stabilization, MDM2 induction, and p21 induction after 5 Gy. MDMX siRNA (200 nM) in U2OS cells increased p53 target induction after 10 Gy and made DNA synthesis inhibition after gamma irradiation significantly more efficient by BrdU ELISA (n=4).
Methods
- Cell lines included MCF7, U2OS, H1299, Saos2, HCT116 wild-type/p53-null/Chk2-null, ATM-deficient Hs235.Sk, and normal human skin fibroblasts; experiments used MDMX point mutants, MDMX siRNA, retrovirus, ionizing radiation, MG132, caffeine, cycloheximide, and MDM2 antisense oligonucleotide.
- Protein analysis used Western blot, gradient gel electrophoresis, immunoprecipitation, GST-MDM2 pull-down, calf intestinal phosphatase treatment, and BrdU incorporation ELISA; phosphorylation-specific antibodies against PS342 and PS367 were generated and validated.
- Phosphorylation site mapping used FLAG-MDMX affinity purification, trypsin digestion, and LCQ DECA XP Plus ion trap MS/MS with SEQUEST/MUQUEST/FUZZYIONS; 32P metabolic labeling with 2-D phospho-amino-acid analysis and in vitro kinase reactions with ATM, Chk1, Chk2, Akt1, and CK1α were also performed.
Limitations
- Stated in the paper: lack of a viable Chk1-null mammalian cell line and strong toxicity of Chk1 siRNA hampered investigation of Chk1’s role; lack of a PS403 antibody precluded testing direct ATM modification of S403; more rigorous testing of cooperative phosphorylation requires gene replacement to avoid MDMX overexpression; the Chk2-null result differed from a prior study, possibly due to experimental conditions.
- Evident from the text: many conclusions rely on transfected/overexpressed MDMX and single versus triple mutants, with single mutants showing only minor differences in U2OS p53 activation; no animal models are reported, and the authors note Chk2 effects may be subtle and cell-line/damage-dose dependent.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 39 cited sources checked · 0 supported · 0 flagged
- Findingown data
DNA damage induces degradation of MDMX.
“We found that DNA damage induces ATMdependent phosphorylation and degradation of MDMX.”
- Also stated in: § DNA damage induces degradation of MDMX · plain
“MDMX was stable before irradiation but was rapidly degraded after DNA damage (Figure 1C).”
Quote in the paperSubstantial claim - Also stated in: § DNA damage induces degradation of MDMX · plain
- Findingown data
Loss of ATM prevents p53 stabilization after DNA damage.
“Loss of ATM prevents MDMX degradation and p53 stabilization after DNA damage.”
Quote in the paperSubstantial claim - Findingown data
Mutation of MDMX at S342, S367, and S403 each confers partial resistance to MDM2-mediated ubiquitination and degradation.
“Mutation of MDMX on S342, S367, and S403 each confers partial resistance to MDM2-mediated ubiquitination and degradation.”
- Also stated in: § Phosphorylation site mutations reduce ubiquitination and degradation by MDM2 · plain
“The results showed that mutating S342, S367, and S403 each resulted in reduced poly-ubiquitination by MDM2, with S367 having the most significant effect (Figure 6C).”
Quote in the paperSubstantial claim - Also stated in: § Phosphorylation site mutations reduce ubiquitination and degradation by MDM2 · plain
- Findingown data
MDMX is phosphorylated on S342, S367, and S403 after DNA damage.
“Phosphorylation of MDMX on S342, S367, and S403 were detected by mass spectrometric analysis, with the first two sites confirmed by phosphopeptide-specific antibodies.”
- Also stated in: § Identification of phosphorylation sites on MDMX · plain
“Analysis of the MS results led to detection of phosphorylation on S161 (post-IR), S342 (preand post-IR), S367 (pre-and post-IR), S391 (post-IR), and S403 (post-IR).”
Quote in the paperSubstantial claim - Also stated in: § Identification of phosphorylation sites on MDMX · plain
- Findingown data
Phosphorylation of MDMX at S342 and S367 in vivo requires Chk2.
“Phosphorylation of S342 and S367 in vivo require the Chk2 kinase.”
- Also stated in: § Phosphorylation of MDMX by Chk2 · hedged
“Loss of Chk2 abrogated the induction of S342 and S367 phosphorylation after irradiation (Figure 8C), suggesting that Chk2 is required for the phosphorylation of both sites in vivo.”
Quote in the paperSubstantial claim - Also stated in: § Phosphorylation of MDMX by Chk2 · hedged
- Findingown data
MDM2 expression is required for rapid degradation of phosphorylated MDMX after DNA damage.
“Inhibition of MDM2 expression led to the accumulation of slow migrating MDMX after radiation, similar to the effect of proteasome inhibition by MG132 (Figure 2C).”
- Also stated in: § Phosphorylation of MDMX promotes degradation by MDM2 · plain
“Therefore, MDM2 expression was required for the rapid degradation of phosphorylated MDMX after DNA damage.”
Quote in the paperSubstantial claim - Also stated in: § Phosphorylation of MDMX promotes degradation by MDM2 · plain
- Findingown data
Chk2 stimulates MDMX ubiquitination and degradation by MDM2.
“Chk2 also stimulates MDMX ubiquitination and degradation by MDM2.”
- Also stated in: § Phosphorylation of MDMX by Chk2 · boosted
“As expected, cotransfection of Chk2 strongly stimulated MDMX ubiquitination and degradation (Figure 9B).”
Quote in the paperSubstantial claim - Also stated in: § Phosphorylation of MDMX by Chk2 · boosted
- Findingown data
Phosphopeptide-specific antibodies confirm phosphorylation of MDMX at S342 and S367.
“with the first two sites confirmed by phosphopeptide-specific antibodies.”
- Also stated in: § Detection of MDMX phosphorylation by peptide-specific antibodies · plain
“The specificity of the antibodies was confirmed by the lack of binding to un-phosphorylated His6-MDMX produced in Escherichia coli (Figure 7A and B).”
Quote in the paperSubstantial claim - Also stated in: § Detection of MDMX phosphorylation by peptide-specific antibodies · plain
- Findingown data
ATM activity is required for MDMX phosphorylation after DNA damage.
“ATMdeficient fibroblasts failed to induce MDMX mobility shift and degradation after DNA damage (Figure 3C), demonstrating that ATM activity was required for this response.”
- Also stated in: § Phosphorylation of MDMX by Chk2 · plain
“Treatment of U2OS-MDMX cells with caffeine blocked induction of S342 and S367 phosphorylation after gamma irradiation (Figure 8B).”
Quote in the paperSubstantial claim - Also stated in: § Phosphorylation of MDMX by Chk2 · plain
- Findingown data
DNA damage induces phosphorylation of MDMX.
“We found that DNA damage induces ATMdependent phosphorylation and degradation of MDMX.”
- Also stated in: § Phosphorylation of MDMX promotes degradation by MDM2 · hedged
“This treatment restored the mobility of the slow-migrating MDMX (Figure 2A), suggesting that DNA damage induced phosphorylation of MDMX.”
Quote in the paperSubstantial claim - Also stated in: § Phosphorylation of MDMX promotes degradation by MDM2 · hedged
- Findingown data
Phosphorylated MDMX is selectively bound by MDM2.
“The results showed that after irradiation, MDM2 co-precipitated more phosphorylated forms of MDMX than the unmodified form, despite both forms were present at comparable levels in the cell lysate (Figure 2D).”
- Also stated in: § Phosphorylation of MDMX promotes degradation by MDM2 · plain
“Incubation of GST-MDM2-loaded beads with HCT116 extract also selectively captured phosphorylated endogenous MDMX (Figure 2E).”
Quote in the paperSubstantial claim - Also stated in: § Phosphorylation of MDMX promotes degradation by MDM2 · plain
- Findingown data
MDMX phosphorylation occurs before p53 stabilization after ionizing irradiation.
“MDMX phosphorylation was detectable 15 min after IR in MCF7 cells (Figure 3A).”
- Also stated in: § ATM is required for stimulating MDMX phosphorylation · plain
“Significant stabilization of p53 was detected at the 2 and 4-h time points, correlating with the degradation of phosphorylated forms of MDMX.”
Quote in the paperSubstantial claim - Also stated in: § ATM is required for stimulating MDMX phosphorylation · plain
- Findingown data
Reduction of MDMX level by RNAi enhances the p53 response to DNA damage.
“Reduction of MDMX level by RNAi enhances p53 response to DNA damage.”
- Also stated in: § Reduction of MDMX level increases p53 response to DNA damage · plain
“However, higher expression levels of p53 target MDM2 and p21 were induced by gamma radiation compared to control siRNA-treated cells.”
Quote in the paperSubstantial claim - Also stated in: § Reduction of MDMX level increases p53 response to DNA damage · plain
- Findingown data
DNA synthesis inhibition after gamma irradiation is significantly more efficient in MDMX knockdown cells compared to controls.
“The results showed that DNA synthesis inhibi- tion after gamma irradiation was significantly more efficient in MDMX knockdown cells compared to controls (Figure 4B).”
Quote in the paperSubstantial claim - Findingown data
CK1 alpha did not target S342 and S367 in vitro.
“The casein kinase 1 alpha isoform that binds and phosphorylates MDMX in the central region in such reactions (Chen et al, 2005) did not target S342 and S367 (Figure 8A).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Chen et al, 2005 source
Not checked in the free run.
- Findingown data
After DNA damage, MDMX is phosphorylated in an ATM- and Chk2-dependent manner.
“Results described above showed that MDMX undergoes significant phosphorylation and degradation after DNA damage in an ATM and Chk2-dependent fashion.”
- Also stated in: § Discussion · boosted
“In summary, we have shown that DNA damage induces phosphorylation of MDMX through an ATM and Chk2dependent pathway, resulting in the degradation of MDMX by MDM2.”
Quote in the paperSubstantial claim - Also stated in: § Discussion · boosted
- Findingown data
Knockout of Chk2 alone can measurably affect MDMX degradation and p53 activation under certain conditions such as gamma irradiation.
“Although multiple phosphorylations are necessary for a complete phenotype, our results showed that knockout of Chk2 alone can have measurable effects on MDMX degradation and p53 activation under certain conditions such as gamma irradiation.”
Quote in the paperSubstantial claim - Findingown data
A slower migrating form of MDMX accumulates 3-6 h after DNA damage in MCF7 and SJSA cells treated with gamma radiation and MG132.
“Gradient gel analysis of endogenous MDMX from MCF7 and SJSA cells treated with gamma radiation and MG132 revealed that a slower migrating form of MDMX accumulated 3-6 h after DNA damage (Figure 1D).”
Quote in the paperSubstantial claim - Findingown data
Basal phosphorylation of MDMX at S342 and S367 is present in nonirradiated cells.
“Phosphorylation signals were detectable in the nonirradiated MDMX sample for S342 and S367, suggesting the presence of basal phosphorylation.”
- Also stated in: § Detection of MDMX phosphorylation by peptide-specific antibodies · plain
“The results showed that low levels of MDMX phosphorylation on S342 and S367 were detected in the absence of DNA damage (Figure 7A and B), consistent with MS results.”
Quote in the paperNot a substantial claim - Also stated in: § Detection of MDMX phosphorylation by peptide-specific antibodies · plain
- Findingown data
Mutation of S342, S367, and S403 significantly blocks mobility shift after DNA damage.
“The results showed that mutation of S342, S367, and S403 significantly blocked mobility shift after DNA damage (Figure 6A), suggesting that phosphorylation of these serine residues contributed to the mobility shift.”
Quote in the paperSubstantial claim - Findingown data
S367 is not modified by Akt1 in vitro despite being in an optimal sequence context for Akt1.
“Although S367 is in an optimal sequence context for Akt1, it was not modified by Akt1 in vitro (Figure 8A).”
Quote in the paperNot a substantial claim - Findingown data
Gamma irradiation significantly increases phosphorylation levels of S342 and S367 in MCF7 cells in the presence of MG132.
“Gamma irradiation significantly increased the phosphorylation levels of S342 and S367 in MCF7 cells in the presence of MG132 (Figure 7A and B).”
Quote in the paperSubstantial claim - Findingown data
The 367A mutant is significantly more resistant to degradation by MDM2.
“The results showed that within the sensitivity limit of this assay, the 367A mutant was significantly more resistant to degradation by MDM2 (Figure 6B), suggesting that phosphorylation of S367 may be critical for this function.”
Quote in the paperSubstantial claim - Findingown data
Mutating adjacent phosphorylation sites has no effect on phosphorylation of S342 and S367.
“The results showed that mutating the adjacent sites had no effect on the phosphorylation of S342 and S367 (Figure 7D).”
Quote in the paperSubstantial claim - Findingown data
Most phosphorylation sites identified on MDMX lie near the C-terminal RING domain.
“Most of the phosphorylation sites identified on MDMX are localized near the C-terminal RING domain, consistent with the observed impact on MDM2 binding and degradation.”
Quote in the paperNot a substantial claim - Findingown data
Mutations on S161 and S391 have little effect on MDMX ubiquitination.
“Mutations on S161 and S391 had little effect on MDMX ubiquitination.”
Quote in the paperSubstantial claim - Findingcitation
After DNA damage, S367 carries the most phosphate among MDMX residues.
“In vivo 32 P phosphate metabolic labeling and phosphopeptide analysis of MDMX revealed that S367 is the most heavily phosphorylated residue on MDMX after DNA damage (LeBron and Chen, unpublished observation).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites LeBron and Chen, unpublished observation
Not checked in the free run.
- Findingown data
The deficiency observed in HCT116-Chk2-/- cells was reproducible in a range between 5 and 20 Gy.
“Irradiation dosage alone is probably not the cause, since the deficiency we observed in the HCT116-Chk2À/À cells were reproducible in a range between 5 and 20 Gy (data not shown).”
Quote in the paperNot a substantial claim - Findingown data
The 367A mutation does not prevent MDM2 binding.
“Analysis of the cotransfected cells by MDM2 IP-MDMX Western blot showed that the 367A mutation did not prevent MDM2 binding (Figure 6B).”
Quote in the paperSubstantial claim - Findingown data
ATM activity is required for MDMX mobility shift and degradation after DNA damage.
“ATMdeficient fibroblasts failed to induce MDMX mobility shift and degradation after DNA damage (Figure 3C), demonstrating that ATM activity was required for this response.”
Quote in the paperSubstantial claim - Findingown data
Chk1 efficiently modifies MDMX S342 in vitro.
“Chk1 also efficiently modifies S342 in vitro, it is likely that Chk1 plays a role in the basal phosphorylation of MDMX in the absence of DNA damage.”
Quote in the paperNot a substantial claim - Findingown data
The S367 mutation produces the largest change in MDMX ubiquitination and stability.
“In fact, mutation of S367 has the most dramatic effect on MDMX ubiquitination and stability (Figure 6).”
Quote in the paperSubstantial claim - Findingown data
Ectopically expressed MDMX in p53-null H1299 or Saos2 cells with low MDM2 shows slow migrating MDMX after gamma irradiation without MG132.
“When MDMX was ectopically expressed in p53-null H1299 or Saos2 cells with very low levels of MDM2, the accumulation of slow migrating MDMX was evident after gamma irradiation without MG132 treatment, possibly due to saturation of the MDM2 degradation system (Figure 1D).”
Quote in the paperSubstantial claim - Findingown data
In wild-type HCT116 cells, Chk2-A347 reduces S367 phosphorylation, possibly through a dominant-negative effect.
“In wild-type HCT116 cells, Chk2-A347 reduced S367 phosphorylation, possibly through dominant-negative effect (Figure 9A).”
Quote in the paperNot a substantial claim - Findingreasoning
DNA damage-induced phosphorylation of MDMX S342 and S367 strictly requires Chk2.
“However, DNA damage-induced phosphorylation of S342 and S367 strictly requires Chk2.”
Quote in the paperSubstantial claim - Findingown data
The decrease in MDMX level after DNA damage is due to reduced stability.
“These results confirmed that the decrease in MDMX level was due to reduced stability.”
Quote in the paperSubstantial claim - Findingown data
After DNA damage, MDMX is degraded in an ATM- and Chk2-dependent manner.
“Results described above showed that MDMX undergoes significant phosphorylation and degradation after DNA damage in an ATM and Chk2-dependent fashion.”
- Also stated in: § Discussion · boosted
“In summary, we have shown that DNA damage induces phosphorylation of MDMX through an ATM and Chk2dependent pathway, resulting in the degradation of MDMX by MDM2.”
Quote in the paperSubstantial claim - Also stated in: § Discussion · boosted
- Findingown data
Transient MDMX knockdown in U2OS causes a moderate increase in p53 level without DNA damage.
“Transient knock-down of MDMX resulted in moderate increase of p53 level in the absence of DNA damage (Figure 4A).”
Quote in the paperNot a substantial claim - Findingown data
Chk2 phosphorylation of MDMX S342 and S367 promotes MDMX ubiquitination and degradation by MDM2.
“We show here that phosphorylation of MDMX S342 and S367 by Chk2 promote its ubiquitination and degradation by MDM2.”
Quote in the paperSubstantial claim - Premisecitation
Mutations of phosphorylation sites on p53 and MDM2 or knockdown of Chk1 and Chk2 lead to partial or no phenotypes, suggesting additional targets and mechanisms contribute to p53 activation after DNA damage.
“However, mutations of phosphorylation sites for these kinases on p53 and MDM2 or siRNA knockdown of Chk1 and Chk2 kinases lead to partial or no phenotypes (Wu et al, 2002;Ahn et al, 2003;Chao et al, 2003;Sluss et al, 2004), suggesting that additional targets and mechanisms may also contribute to activation of p53 after DNA damage.”
Quote in the paperSubstantial claim0 of 3 sources checked - Interpretationown data
MDMX is probably not directly modified by c-Abl tyrosine kinase, unlike MDM2.
“This suggests that unlike MDM2, MDMX may not be directly modified by the c-Abl tyrosine kinase.”
Quote in the paperNot a substantial claim - Interpretationreasoning
Chk1 likely contributes to basal MDMX phosphorylation in the absence of DNA damage.
“Chk1 also efficiently modifies S342 in vitro, it is likely that Chk1 plays a role in the basal phosphorylation of MDMX in the absence of DNA damage.”
Quote in the paperNot a substantial claim - Interpretationown data
The C-terminal region of MDMX contains sequence important for phosphorylation.
“Therefore, the C-terminal region of MDMX contains sequence important for phosphorylation.”
Quote in the paperSubstantial claim - Premisecitation
A recent study demonstrated phosphorylation of S403 by ATM using a phosphorylation-specific antibody.
“A recent study was able to demonstrate the phosphorylation of S403 by ATM using a phosphorylation-specific antibody (Pereg et al, 2005).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Pereg et al, 2005 source
Not checked in the free run.
- Interpretationown data
Multiple phosphorylation events cooperate to regulate MDMX degradation after DNA damage.
“This result suggested that multiple phosphorylation events cooperate to regulate MDMX degradation after DNA damage.”
Quote in the paperSubstantial claim - Premisecitation
S403 of MDMX is an ATM target site.
“S403 is in a favorable context for ATM and a recent study by Pereg et al (2005) provided direct evidence that it is an ATM target site.”
- Also stated in: § Discussion · plain
“Our results of S403 phosphorylation also corroborate recent findings from Pereg et al (2005) on ATM modification of this site.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Pereg et al (2005) source
Not checked in the free run.
- Also stated in: § Discussion · plain
- Interpretationown data
Reduction of MDMX level sensitizes p53 to DNA damage.
“Therefore, reduction of MDMX level sensitizes p53 to DNA damage.”
Quote in the paperSubstantial claim - Interpretationown data
Modification at each phosphorylation site is independently regulated after DNA damage.
“This result suggested that the modification at each site was independently regulated after DNA damage.”
Quote in the paperSubstantial claim - Interpretationown data
The localization of MDMX phosphorylation sites near the RING domain is consistent with effects on MDM2 binding and degradation.
“Most of the phosphorylation sites identified on MDMX are localized near the C-terminal RING domain, consistent with the observed impact on MDM2 binding and degradation.”
Quote in the paperSubstantial claim - Premisecitation
Different conclusions have emerged from work with Chk2-null mice, Chk2-null HCT116 cells, and Chk2 small interfering RNA.
“Studies using Chk2-null mice, Chk2-null HCT116 cells, and Chk2 siRNA resulted in different conclusions (Zhang et al, 1998;Chehab et al, 2000;Shieh et al, 2000;Ahn et al, 2003; Jallepalli et al, 2003).”
Quote in the paperNot a substantial claim0 of 3 sources checked - Interpretationown data
Irradiation dosage alone is probably not the cause of the discrepancy with a previous study.
“Irradiation dosage alone is probably not the cause, since the deficiency we observed in the HCT116-Chk2À/À cells were reproducible in a range between 5 and 20 Gy (data not shown).”
Quote in the paperNot a substantial claim - Interpretationown data
ATM or ATR is important for induction of MDMX phosphorylation after DNA damage.
“Therefore, ATM or ATR was important for the induction of MDMX phosphorylation after DNA damage.”
Quote in the paperSubstantial claim - Interpretationreasoning
MDM2 controls how stable MDMX is after mitogenic stress and DNA damage.
“This work and our previous study also reveal an important function of MDM2 in regulating MDMX stability in response to mitogenic stress and DNA damage.”
Quote in the paperSubstantial claim - Interpretationreasoning
DNA damage-induced MDMX phosphorylation and degradation contributes to p53 activation after DNA damage.
“This event contributes to p53 activation after DNA damage.”
Quote in the paperSubstantial claim - Interpretationreasoning
How MDM2 and MDMX interact with each other and with stress signaling is probably important for the dynamic control of p53.
“The intricate interplay between MDM2 and MDMX and their connection to stress signaling pathways are likely to be critical for the dynamic regulation of p53.”
Quote in the paperNot a substantial claim - Interpretationown data
Part of Chk2's effect on p53 regulation occurs through its phosphorylation of MDMX.
“Therefore, Chk2 contributes to p53 regulation in part through phosphorylation of MDMX.”
Quote in the paperSubstantial claim - Interpretationreasoning
Together with other possible modifications on several p53 pathway components, these changes produce timely p53 activation and G1 arrest after DNA damage.
“It is apparent that combination of these and possibly additional changes on multiple targets in the p53 pathway lead to timely activation of p53 and G1 arrest in response to DNA damage.”
Quote in the paperSubstantial claim - Interpretationreasoning
Loss of Chk2 by itself may produce small effects on p53 responses that vary with cell line and damage dose and are often missed.
“However, a single defect in Chk2 alone may have subtle, cell line and damage dose-dependent effects on p53 response that often elude detection.”
Quote in the paperNot a substantial claim
- May combine two claims. 42
- Classified as probably not a substantial claim. 17
May combine two claims.
Findingown dataSerine carries most of the phosphate on MDMX; threonine is modified less, and tyrosine modification was not detected.
“In vivo metabolic labeling revealed that MDMX is predominantly phosphorylated on serine, with minor modifications on threonine and no detectable modification on tyrosine.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataChk1 modifies S342 and S367 in vitro, with strong preference for S342.
“Western blot showed that Chk1 modified S342 and S367, but with strong preference for S342.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataEndogenous MDMX phosphorylated on S342 or S367 is rapidly degraded after DNA damage and accumulates only after MG132 treatment.
“Furthermore, endogenous MDMX phosphorylated on S342 or S367 were rapidly degraded after DNA damage and only accumulate after MG132 treatment.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataATM immunoprecipitated from transfected cells phosphorylated p53 S15 but did not show specific modification of MDMX on S342 and S367.
“ATM immunoprecipitated from transfected cells phosphorylated S15 of p53 but did not show specific modification of MDMX on S342 and S367.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataCaffeine partially inhibits MDMX mobility shift and degradation after radiation and blocks p53 stabilization and MDM2 and p21 induction.
“This treatment partially inhibited the mobility shift and degradation of MDMX after radiation (Figure 3B).”
- Also stated in: § ATM is required for stimulating MDMX phosphorylation · plain
“As expected, caffeine also blocked stabilization of p53 and induction of MDM2 and p21 (Figure 3B and data not shown).”
Quote in the paperSubstantial claim- Also stated in: § ATM is required for stimulating MDMX phosphorylation · plain
May combine two claims.
Findingown dataMDMX downregulation occurs in p53-deficient HCT116 cells and p53-mutant DLD1 and C33A cells without induction of MDM2.
“However, further tests of a panel of cell lines showed that MDMX downregulation also occur in p53-deficient HCT116 cells and p53-mutant DLD1 and C33A cells without induction of MDM2 (Figure 1B).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataDeletion of the MDMX C-terminal RING domain causes complete loss of mobility shift after DNA damage, whereas deletion of the N-terminal p53-binding domain does not prevent phosphorylation.
“The results indicated that deletion of the MDMX C-terminal RING domain caused a complete loss of mobility shift after DNA damage, whereas deletion of the N-terminal p53-binding domain did not prevent phosphory- lation (Figure 5B).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataMDMX is mainly phosphorylated on serine in vivo, with minor threonine and no detectable tyrosine phosphorylation.
“Phospho-amino-acid analysis showed that MDMX was mainly phosphorylated on serine in vivo, with minor labeling of threonine and no detectable phosphorylation of tyrosine (Figure 5A).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataMDMX ubiquitination and degradation by MDM2 can occur in both wild-type and Chk2-null HCT116 cells, indicating Chk2 is not absolutely necessary under these conditions.
“In cotransfection experiments, MDMX ubiquitination and degradation by MDM2 can occur in both wild-type and Chk2-null HCT116 cells, suggesting that Chk2 was not absolutely necessary under these conditions.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataDNA-damaging agents induce MDMX phosphorylation, whereas taxol and nocodazole do not.
“The results showed that agents that can induce DNA damage were all capable of inducing MDMX phosphorylation.Microtubule targeting agents taxol and nocodazole did not cause MDMX mobility shift (Figure 2B), suggesting that the effect was unique to DNA-damaging drugs.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataChk2 modifies both S342 and S367 in vitro, with strong preference for S367.
“Chk2 modified both S342 and S367, but with strong preference for S367 (Figure 8A).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataIn HCT116-Chk2-/- cells after gamma irradiation, MDMX degradation is much less efficient than in wild-type, and MDM2 and p21 induction and p53 stabilization are reduced.
“When the HCT116-Chk2À/À cells were compared to wildtype HCT116 after gamma irradiation (5 Gy), we reproducibly found that MDMX degradation was much less efficient (Figure 9C).MDM2 and p21 induction and p53 stabilization were also reduced compared to wild-type cells (Figure 9C).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataThe triple alanine MDMX mutant shows significant resistance to degradation after DNA damage and inhibits p53 activation more efficiently than wild-type MDMX.
“However, the triple alanine compound mutant (MDMX-3A) showed significant resistance to degradation after DNA damage, and inhibited p53 activation more efficiently than wild-type MDMX (Figure 6D).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataCotransfection of MDMX and Chk2 into HCT116-Chk2-/- cells restores phosphorylation of MDMX S367 after gamma irradiation, whereas kinase-dead Chk2-A347, activated myr-Akt1, and CK1a have no effect.
“Cotransfection of MDMX and Chk2 plasmid into HCT116-Chk2À/À cells restored the phosphorylation of MDMX S367 after gamma irradiation, whereas kinase-dead Chk2-A347 mutant, activated myr-Akt1 and CK1a had no effect (Figure 9A).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataExpression of MDM2 stimulates MDMX ubiquitination more significantly in wild-type HCT116 compared to Chk2-null cells, consistent with Chk2 being a facilitator.
“However, expression of MDM2 stimulated MDMX ubiquitination more significantly in wild-type HCT116 compared to the Chk2-null cells (Figure 9B), consistent with Chk2 being a facilitator.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataChk2 phosphorylates MDMX at S342 and S367 both in vitro and in vivo.
“Of the three functionally relevant phosphorylation sites identified in this study, S342 and S367 are targets of Chk2 in vitro and in vivo.”
- Also stated in: § Discussion · boosted
“We show here that Chk2 is directly involved in the phosphorylation of MDMX on S342 and S367.”
Quote in the paperSubstantial claim- Also stated in: § Discussion · boosted
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Findingown dataWeak modification of S342 by Akt1 was detected in vitro, with unclear significance.
“Weak modification of S342 by Akt1 was detected, the significance of this reaction is not clear at present.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationIonizing irradiation promotes MDMX nuclear translocation and degradation by proteasomes.
“DNA damage induced by ionizing irradiation also promotes MDMX nuclear translocation and degradation by the proteasomes (Li et al, 2002;Pan and Chen, 2003).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites Li et al, 2002
Not checked in the free run.
- cites Pan and Chen, 2003 source
Not checked in the free run.
Classified as probably not a substantial claim.
PremisecitationMDMX cooperates with MDM2 to promote p53 degradation.
“Recent evidence showed that MDMX cooperates with MDM2 to promote p53 degradation (Gu et al, 2002).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Gu et al, 2002
Not checked in the free run.
May combine two claims.
PremisecitationMDMX binds p53 and inhibits its transcriptional function, but alone does not promote p53 ubiquitination or degradation in vivo.
“MDMX shares strong homology to MDM2 at the amino-acid sequence level and can bind to p53 and inhibit its transcriptional function.However, MDMX alone does not promote p53 ubiquitination or degradation in vivo (Stad et al, 2001).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Stad et al, 2001 source
Not checked in the free run.
May combine two claims.
PremisecitationMDMX-null mice die in utero in a p53-dependent manner, and this lethality is rescued by crossing into a p53-null background.
“Several studies showed that MDMX-null mice also die in utero in a p53-dependent fashion, which can be rescued by crossing into the p53-null background (Finch et al, 2002;Migliorini et al, 2002;Parant et al, 2002).”
Quote in the paperNot a substantial claim0 of 3 sources checkedClassified as probably not a substantial claim. May combine two claims.
PremisecitationMDM2 binds p53 and acts as an ubiquitin E3 ligase to promote p53 degradation by proteasomes.
“P53 turnover is regulated by MDM2, which binds p53 and functions as an ubiquitin E3 ligase to promote p53 degradation by the proteasomes (Zhang and Xiong, 2001).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Zhang and Xiong, 2001
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationATM phosphorylates p53 on serine 15, enhancing its transcriptional activity.
“ATM phosphorylates p53 on serine 15, enhancing its transcriptional activity (Banin et al, 1998).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Banin et al, 1998 source
Not checked in the free run.
May combine two claims.
InterpretationreasoningAfter DNA damage, MDM2 E3 ligase activity is redirected to MDMX and contributes to p53 activation.
“Therefore, the E3 ligase activity of MDM2 is redirected to MDMX after DNA damage and contributes to p53 activation.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim.
PremisecitationDNA damage induces p53 accumulation by phosphorylation.
“Stress signals such as DNA damage induce p53 accumulation by phosphorylation (Prives and Hall, 1999).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Prives and Hall, 1999 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationATM activates Chk2, which phosphorylates p53 on serine 20 and inhibits MDM2 binding.
“ATM also activates Chk2, which in turn phosphorylates p53 on serine 20 and inhibits MDM2 binding (Shieh et al, 1997;Banin et al, 1998;Chehab et al, 2000;Shieh et al, 2000).”
Quote in the paperNot a substantial claim0 of 3 sources checkedMay combine two claims.
PremisecitationDNA damage induces MDMX degradation in p53-deficient cells without induction of MDM2.
“A recent study showed that DNA damage also induces MDMX degradation in p53-deficient cells, without induction of MDM2 (Kawai et al, 2003).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Kawai et al, 2003 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationATM functions as the primary signal transducer of DNA double-strand breaks.
“ATM functions as the primary signal transducer of DNA double-strand breaks (Shiloh, 2003).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Shiloh, 2003 source
Not checked in the free run.
Classified as probably not a substantial claim.
PremisecitationATM is important for rapid p53 activation after ionizing radiation, as shown by delayed p53 accumulation in ATM-deficient cells.
“The importance of ATM in rapid p53 activation after ionizing radiation (IR) was revealed by the delay in p53 accumulation in ATM-deficient cells (Kastan et al, 1993).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Kastan et al, 1993 source
Not checked in the free run.
May combine two claims.
PremisecitationMDMX can be ubiquitinated and degraded by MDM2.
“Several reports showed that MDMX can be ubiquitinated and degraded by MDM2 (De Graaf et al, 2003;Kawai et al, 2003;Pan and Chen, 2003).”
Quote in the paperSubstantial claim0 of 3 sources checkedMay combine two claims.
PremisecitationMDMX and MDM2 form heterodimers through their C-terminal RING domains, and the MDM2 RING domain alone is sufficient to degrade MDMX.
“MDMX and MDM2 form heterodimers through the C-terminal RING domains and the MDM2 RING domain alone is sufficient to degrade MDMX (Sharp et al, 1999;Tanimura et al, 1999;Pan and Chen, 2003).”
Quote in the paperSubstantial claim0 of 3 sources checkedMay combine two claims.
Interpretationown dataPhosphorylated MDMX binds MDM2 more efficiently, which may cause its selective degradation by MDM2.
“These results showed that phosphorylated MDMX bound to MDM2 more efficiently, which may cause its selective degradation by MDM2.”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown dataDNA damage activates ATM and then Chk2.
“The current results suggest that DNA damage activates ATM and subsequently Chk2.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationreasoningA population of MDMX is phosphorylated and then rapidly degraded after ionizing irradiation.
“This suggested that a population of MDMX was phosphorylated and then rapidly degraded after ionizing irradiation.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationThe role of ATM in p53 response is well established, but the significance of Chk2 is debated.
“Although a role of ATM in p53 response is well established, the significance of Chk2 is still a matter of debate.”
Quote in the paperNot a substantial claim0 of 3 sources checkedMay combine two claims.
Interpretationown dataChk2 plays a role in regulating the p53 response to gamma irradiation, possibly through promoting degradation of MDMX.
“These results showed that Chk2 plays a role in regulating p53 response to gamma irradiation, possibly through promoting degradation of MDMX.”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown dataPhosphorylation of S342, S367, and S403 may each contribute to stimulating poly-ubiquitination and degradation by MDM2, with S367 having the most dominant role.
“Therefore, phosphorylation of S342, S367, and S403 may each contribute to stimulating poly-ubiquitination and degradation by MDM2, with S367 having the most dominant role.”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown dataDegradation of MDMX after DNA damage facilitates p53 activation and cell cycle arrest.
“These results suggested that degradation of MDMX after DNA damage facilitates p53 activation and cell cycle arrest.”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown dataMDMX phosphorylation occurs before p53 stabilization after ionizing irradiation, suggesting that degradation of MDMX contributes to p53 activation.
“Therefore, MDMX phosphorylation occurs before p53 stabilization after ionizing irradiation, suggesting that degradation of MDMX contributes to p53 activation.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationreasoningMultiple phosphorylation in the MDMX C-terminal region may cause conformational changes in the RING domain, increasing MDM2 binding and leading to MDMX ubiquitination and degradation.
“Multiple phosphorylation of MDMX C-terminal region may lead to conformational changes in the MDMX RING domain, increasing the affinity for MDM2 binding, and leading to ubiquitination and degradation of MDMX.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
PremisecitationA previous study using the same HCT116-Chk2-/- cell line reported that Chk2 knockout did not affect p53 response to higher doses of ionizing irradiation.
“The results in Figure 9C were unexpected since a previous study using the same HCT116-Chk2À/À cell line reported that Chk2 knockout did not affect p53 response to higher doses (12 Gy) of ionizing irradiation (Jallepalli et al, 2003).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Jallepalli et al, 2003 source
Not checked in the free run.
May combine two claims.
Interpretationown dataATM is required for activation of Chk2, which mediates S342 and S367 phosphorylation.
“This is consistent with the interpretation that ATM is required for activation of Chk2, which mediates S342 and S367 phosphorylation.”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown dataPhosphorylation of S367 is not necessary for MDM2 binding but may further stimulate MDM2 binding or induce a conformational change favoring degradation.
“Therefore, phosphorylation of S367 was not necessary for MDM2 binding, but may further stimulate MDM2 binding or induce a conformational change that favor degradation by MDM2.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationPhosphorylation of p53 S15 and S20 by ATM and Chk2 stimulates p53 transcription activation and reduces MDM2 binding.
“Previous studies showed that phosphorylation of S15 and S20 of p53 by ATM and Chk2 stimulate p53 transcription activation function and reduce MDM2 binding.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationDNA damage also accelerates MDM2 degradation through a mechanism requiring its own RING domain.
“A recent study showed that DNA damage also accelerates MDM2 degradation through a mechanism that requires its own RING domain (Stommel and Wahl, 2004).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Stommel and Wahl, 2004 source
Not checked in the free run.
May combine two claims.
InterpretationreasoningRemoving MDMX would help activate p53 by freeing p53 from MDMX and by lowering MDM2's E3 ligase activity.
“Elimination of MDMX would facilitate p53 activation by relieving p53 from MDMX binding, and reducing the E3 ligase activity of MDM2.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataProtein expression levels were confirmed by analyzing a matching set of 8C6 immunoprecipitates with MDMX Western blot.
“An identical set of 8C6 IP samples was analyzed by MDMX Western blot to confirm protein expression level.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Premisecitation14-3-3 copurifies with MDMX.
“We have recently found that 14-3-3 copurifies with MDMX (Chen et al, 2005).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Chen et al, 2005 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThe phosphorylated form of MDMX S367 may serve as a 14-3-3 binding site.
“It is noteworthy that phosphorylated S367 of MDMX is a potential 14-3-3 binding site (Tzivion et al, 2001).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Tzivion et al, 2001 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Premisecitationc-Abl phosphorylation of MDM2 Y394 and ATM phosphorylation of S395 lower MDM2's capacity to promote p53 degradation.
“Phosphorylation of MDM2 Y394 by c-Abl and S395 by ATM reduce its ability to promote p53 degradation.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataE. coli-expressed His6-MDMX served as a control to test antibody crossreactivity with unphosphorylated MDMX.
“His6-MDMX expressed in E. coli was used as a control for crossreactivity to nonphosphorylated MDMX.”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationreasoningStress signals can redirect MDM2's E3 ligase activity toward either p53 or MDMX, so MDM2 has both negative and positive effects on p53 function.
“The ubiquitin E3 ligase activity of MDM2 can be switched between targeting p53 or MDMX by stress signals, thus having both negative and positive effects on p53 function.”
Quote in the paperSubstantial claim
The paper relies on this without support.
Caffeine's inhibition of MDMX phosphorylation and degradation after radiation is due to inhibition of ATM/ATR rather than other caffeine effects.
“MCF7 cells were treated with caffeine to inhibit ATM/ATR.”
“This treatment partially inhibited the mobility shift and degradation of MDMX after radiation (Figure 3B).”
The paper relies on this without support.
MDMX siRNA and stable knockdown specifically reduce MDMX levels without off-target effects.
“U2OS cells were transfected with MDMX siRNA for 48 h, followed by treatment with 10 Gy gamma irradiation.”
“Similar results were also observed using MCF7 cells with stable knockdown of MDMX (data not shown).”
The paper relies on this without support.
The Chk2-A347 mutant is kinase-dead and can act as a dominant-negative inhibitor of Chk2.
“kinase-dead Chk2-A347 mutant, activated myr-Akt1 and CK1a had no effect (Figure 9A).”
“In wild-type HCT116 cells, Chk2-A347 reduced S367 phosphorylation, possibly through dominant-negative effect (Figure 9A).”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Phosphorylation of Mdm2 and Mdmx at serine residues close to the RING domain by ATM or ATM-dependent kinases leads to accelerated auto-degradation of both Mdm2 and Mdmx, with consequent p53 accumulation and activation.
“Additionally, phosphorylation of Mdm2 and Mdmx at serine residues close to the RING domain by ATM or ATM-dependent kinases leads to accelerated auto-degradation of both Mdm2 [54] and Mdmx [41,55–58], with consequent p53 accumulation and activation.”
From The p53 orchestra: Mdm2 and Mdmx set the tone (2010) · cites this paper as [55]
Chk1 and Chk2 failed to phosphorylate S386 and S429 in vitro, but phosphorylated MDMX S367.
“Furthermore, Chk1 and Chk2 failed to phosphorylate S386 and S429 in vitro, but phosphorylated the positive control site MDMX S367 (Chen et al, 2005).”
From ATM activates p53 by regulating MDM2 oligomerization and E3 processivity (2009) · cites this paper as Chen et al, 2005
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Figure 8A names a different phosphosite antibody
MinorThe Figure 8A caption says the kinase products were probed with PS467, whereas the described assay and antibody are for S367. The caption therefore identifies a different phosphosite from the one reported in the results.
“The reaction products were analyzed by Western blot using PS342, PS467, and p53PS15 antibodies.”
“Western blot showed that Chk1 modified S342 and S367, but with strong preference for S342.Chk2 modified both S342 and S367, but with strong preference for S367 (Figure 8A).”
Cites
WAF1, a potential mediator of p53 tumor suppression
El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., & Vogelstein, B. (1993) · Cell · doi:10.1016/0092-8674(93)90500-p · Cited by 8,321 · see citing works
DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation
Bakkenist, C. J., & Kastan, M. B. (2003) · Nature · doi:10.1038/nature01368 · Cited by 3,466 · see citing works
Kastan, M. B., Zhan, Q., El-Deiry, W. S., Carrier, F., Jacks, T., Walsh, W. V., Plunkett, B. S., Vogelstein, B., & Fornace, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90593-2 · Cited by 3,047 · see citing works
ATM and related protein kinases: safeguarding genome integrity
Shiloh, Y. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1011 · Cited by 2,577 · see citing works
DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2
Shieh, S.-Y., Ikeda, M., Taya, Y., & Prives, C. (1997) · Cell · doi:10.1016/s0092-8674(00)80416-x · Cited by 2,100 · see citing works
Enhanced Phosphorylation of p53 by ATM in Response to DNA Damage
Banin, S., Moyal, L., Shieh, S.-Y., Taya, Y., Anderson, C. W., Chessa, L., Smorodinsky, N. I., Prives, C., Reiss, Y., Shiloh, Y., et al. (1998) · Science · doi:10.1126/science.281.5383.1674 · Cited by 1,797 · see citing works
Zhang, Y., Xiong, Y., & Yarbrough, W. G. (1998) · Cell · doi:10.1016/s0092-8674(00)81401-4 · Cited by 1,626 · see citing works
Chk1 and Chk2 kinases in checkpoint control and cancer
Bartek, J., & Lukas, J. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00110-7 · Cited by 1,513 · see citing works
Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53
de Oca Luna, R. M., Wagner, D. S., & Lozano, G. (1995) · Nature · doi:10.1038/378203a0 · Cited by 1,420 · cited 2× · see citing works
“ATM and Chk2-dependent phosphorylation of MDMX contribute to p53 activation after DNA damage”
BackgroundShieh, S.-Y., Ahn, J., Tamai, K., Taya, Y., & Prives, C. (2000) · Genes & Development · doi:10.1101/gad.14.3.289 · Cited by 972 · see citing works
Substrate Specificities and Identification of Putative Substrates of ATM Kinase Family Members
Kim, S.-T., Lim, D.-S., Canman, C. E., & Kastan, M. B. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.53.37538 · Cited by 810 · see citing works
Chk2/hCds1 functions as a DNA damage checkpoint in G<sub>1</sub>by stabilizing p53
Chehab, N. H., Malikzay, A., Appel, M., & Halazonetis, T. D. (2000) · Genes & Development · doi:10.1101/gad.14.3.278 · Cited by 805 · see citing works
Vousden, K. H. (2000) · Cell · doi:10.1016/s0092-8674(00)00171-9 · Cited by 785 · see citing works
The many substrates and functions of ATM.
Kastan, M. B., & Lim, D.-S. (2000) · Nature Reviews Molecular Cell Biology · doi:10.1038/35043058 · Cited by 779 · see citing works
ATM-dependent phosphorylation of Mdm2 on serine 395: role in p53 activation by DNA damage
Maya, R., Balass, M., Kim, S.-T., Shkedy, D., Leal, J.-F. M., Shifman, O., Moas, M., Buschmann, T., Ronai, Z., Shiloh, Y., et al. (2001) · Genes & Development · doi:10.1101/gad.886901 · Cited by 716 · cited 2× · see citing works
“MDM2 phosphorylation on serine 395 by ATM and tyrosine 394 by c-Abl has also been shown to affect MDM2’s ability to regulate p53 (Maya et al, 2001; Goldberg et al, 2003).”
BackgroundMapping of the p53 and mdm-2 Interaction Domains
Chen, J., Maréchal, V., & Levine, A. J. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.7.4107 · Cited by 689 · see citing works
Self-citationMDMX: a novel p53‐binding protein with some functional properties of MDM2.
Shvarts, A., Steegenga, W. T., Riteco, N., van Laar, T., Dekker, P., Bazuine, M., van Ham, R. C., van der Houven van Oordt, W., Hateboer, G., van der Eb, A. J., et al. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00919.x · Cited by 648 · see citing works
Parant, J., Chavez-Reyes, A., Little, N. A., Yan, W., Reinke, V., Jochemsen, A. G., & Lozano, G. (2001) · Nature Genetics · doi:10.1038/ng714 · Cited by 517 · see citing works
Accelerated MDM2 auto‐degradation induced by DNA‐damage kinases is required for p53 activation
Stommel, J. M., & Wahl, G. M. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600145 · Cited by 386 · see citing works
MDM2 interacts with MDMX through their RING finger domains
Tanimura, S., Ohtsuka, S., Mitsui, K., Shirouzu, K., Yoshimura, A., & Ohtsubo, M. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00254-9 · Cited by 324 · see citing works
Migliorini, D., Denchi, E. L., Danovi, D., Jochemsen, A., Capillo, M., Gobbi, A., Helin, K., Pelicci, P. G., & Marine, J.-C. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.15.5527-5538.2002 · Cited by 313 · see citing works
14-3-3 proteins; bringing new definitions to scaffolding
Tzivion, G., Shen, Y. H., & Zhu, J. (2001) · Oncogene · doi:10.1038/sj.onc.1204777 · Cited by 300 · see citing works
Stabilization of the MDM2 Oncoprotein by Interaction with the Structurally Related MDMX Protein
Sharp, D. A., Kratowicz, S. A., Sank, M. J., & George, D. L. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.53.38189 · Cited by 286 · see citing works
Mutual Dependence of MDM2 and MDMX in Their Functional Inactivation of p53
Gu, J., Kawai, H., Nie, L., Kitao, H., Wiederschain, D., Jochemsen, A. G., Parant, J. M., Lozano, G., & Yuan, Z.-M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.c200150200 · Cited by 265 · see citing works
Mapping of the p53 and mdm-2 Interaction Domains
Chen, J., Maréchal, V., & Levine, A. J. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.7.4107-4114.1993 · Cited by 247 · see citing works
Self-citationMDM2 promotes ubiquitination and degradation of MDMX
Pan, Y., & Chen, J. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.15.5113-5121.2003 · Cited by 246 · cited 12× · see citing works
“DNA damage induces degradation of MDMX Previous experiments in our laboratory revealed that MDMX is an ubiquitination substrate for MDM2 (Pan and Chen, 2003).”
BackgroundMethodInfluentialSelf-citationMdmx stabilizes p53 and Mdm2 via two distinct mechanisms
Stad, R., Little, N. A., Xirodimas, D. P., Frenk, R., van der Eb, A. J., Lane, D. P., Saville, M. K., & Jochemsen, A. G. (2001) · The EMBO Reports · doi:10.1093/embo-reports/kve227 · Cited by 234 · see citing works
Tyrosine phosphorylation of Mdm2 by c‐Abl: implications for p53 regulation
Goldberg, Z., Sionov, R. V., Berger, M., Zwang, Y., Perets, R., Etten, R. A. V., Oren, M., Taya, Y., & Haupt, Y. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf384 · Cited by 200 · see citing works
mdmx is a negative regulator of p53 activity in vivo.
Finch, R. A., Donoviel, D. B., Potter, D., Shi, M., Fan, A., Freed, D. D., Wang, C.-Y., Zambrowicz, B., Ramírez‐Solis, R., Sands, A., et al. (2002) · PubMed · Cited by 192 · see citing works
Phosphorylation of Hdmx mediates its Hdm2- and ATM-dependent degradation in response to DNA damage
Pereg, Y., Shkedy, D., de Graaf, P., Meulmeester, E., Edelson-Averbukh, M., Salek, M., Biton, S., Teunisse, A. F. A. S., Lehmann, W. D., Jochemsen, A. G., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408595102 · Cited by 181 · see citing works
Control of p53 ubiquitination and nuclear export by MDM2 and ARF.
Zhang, Y., & Xiong, Y. (2001) · PubMed · Cited by 176 · see citing works
DNA damage-induced MDMX degradation is mediated by MDM2
Kawai, H., Wiederschain, D., Kitao, H., Stuart, J., Tsai, K. K. C., & Yuan, Z.-M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m308295200 · Cited by 163 · cited 7× · see citing works
“A recent study showed that DNA damage also induces MDMX degradation in p53-deficient cells, without induction of MDM2 (Kawai et al, 2003).”
BackgroundResultInfluentialThe Chk2 Tumor Suppressor Is Not Required for p53 Responses in Human Cancer Cells
Jallepalli, P. V., Lengauer, C., Vogelstein, B., & Bunz, F. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m213159200 · Cited by 154 · see citing works
Phosphorylation of Serine 18 Regulates Distinct p53 Functions in Mice
Sluss, H. K., Armata, H., Gallant, J., & Jones, S. N. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.3.976-984.2004 · Cited by 152 · see citing works
Aberrant expression of HDMX proteins in tumor cells correlates with wild-type p53.
Ramos, Y. F., Stad, R. K., Attema, J., Peltenburg, L. T. C., van der Eb, A. J., & Jochemsen, A. G. (2001) · PubMed · Cited by 149 · see citing works
Hdmx protein stability is regulated by the ubiquitin ligase activity of Mdm2
de Graaf, P., Little, N. A., Ramos, Y. F. M., Meulmeester, E., Letteboer, S. J. F., & Jochemsen, A. G. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m213034200 · Cited by 143 · see citing works
Cell Type- and Promoter-specific Roles of Ser18 Phosphorylation in Regulating p53 Responses
Chao, C., Hergenhahn, M., Kaeser, M. D., Wu, Z., Saito, S., Iggo, R., Hollstein, M., Appella, E., & Xu, Y. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m306938200 · Cited by 141 · see citing works
Mutation of Mouse p53 Ser23 and the Response to DNA Damage
Wu, Z., Earle, J., Saito, S., Anderson, C. W., Appella, E., & Xu, Y. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.8.2441-2449.2002 · Cited by 103 · see citing works
Questioning the Role of Checkpoint Kinase 2 in the p53 DNA Damage Response
Ahn, J., Urist, M., & Prives, C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m213185200 · Cited by 99 · see citing works
Regulation of p53-MDMX interaction by casein kinase 1 alpha
Chen, L., Li, C., Pan, Y., & Chen, J. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.15.6509-6520.2005 · Cited by 88 · see citing works
Self-citationDNA Damage Induces MDMX Nuclear Translocation by p53-Dependent and -Independent Mechanisms
Li, C., Chen, L., & Chen, J. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.21.7562-7571.2002 · Cited by 82 · see citing works
Self-citationUbiquitous Induction of p53 in Tumor Cells by Antisense Inhibition of MDM2 Expression
Chen, L., Lu, W., Agrawal, S., Zhou, W., Zhang, R., & Chen, J. (1999) · Molecular Medicine · doi:10.1007/bf03402136 · Cited by 73 · see citing works
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Regulating the p53 pathway: in vitro hypotheses, in vivo veritas
Toledo, F., & Wahl, G. M. (2006) · Nature reviews. Cancer · doi:10.1038/nrc2012 · Cited by 1,286 · see citing works
MDM2, MDMX and p53 in oncogenesis and cancer therapy
Wade, M., Li, Y.-C., & Wahl, G. M. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3430 · Cited by 1,279 · see citing works
The ATM–Chk2 and ATR–Chk1 Pathways in DNA Damage Signaling and Cancer
Smith, J., Tho, L. M., Xu, N., & Gillespie, D. A. (2010) · Advances in cancer research · doi:10.1016/b978-0-12-380888-2.00003-0 · Cited by 1,279 · see citing works
Hydrogen peroxide sensing, signaling and regulation of transcription factors
Marinho, H. S., Real, C., Cyrne, L., Soares, H., & Antunes, F. (2014) · Redox Biology · doi:10.1016/j.redox.2014.02.006 · Cited by 851 · see citing works
The complexity of p53 stabilization and activation
Lavin, M. F., & Gueven, N. (2006) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401925 · Cited by 701 · see citing works
p53 polymorphisms: cancer implications
Whibley, C., Pharoah, P. D. P., & Hollstein, M. C. (2009) · Nature reviews. Cancer · doi:10.1038/nrc2584 · Cited by 667 · see citing works
Oscillations and variability in the p53 system
Geva‐Zatorsky, N., Rosenfeld, N., Itzkovitz, S., Milo, R., Sigal, A., Dekel, E., Yarnitzky, T., Liron, Y., Polak, P. P., Lahav, G., et al. (2006) · Molecular Systems Biology · doi:10.1038/msb4100068 · Cited by 640 · see citing works
Tumour suppression by p53: a role for the DNA damage response?
Meek, D. W. (2009) · Nature reviews. Cancer · doi:10.1038/nrc2716 · Cited by 604 · see citing works
The ATM-mediated DNA-damage response: taking shape
Shiloh, Y. (2006) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2006.05.004 · Cited by 539 · see citing works
Recent advances in apoptosis, mitochondria and drug resistance in cancer cells
Indran, I. R., Tufo, G., Pervaiz, S., & Brenner, C. (2011) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2011.03.010 · Cited by 524 · see citing works
CHK2 kinase in the DNA damage response and beyond
Zannini, L., Delia, D., & Buscemi, G. (2014) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mju045 · Cited by 455 · see citing works
The p53 orchestra: Mdm2 and Mdmx set the tone
Wade, M., Wang, Y. V., & Wahl, G. M. (2010) · Trends in Cell Biology · doi:10.1016/j.tcb.2010.01.009 · Cited by 450 · see citing works
Regulation of the p53 response and its relationship to cancer
Meek, D. W. (2015) · Biochemical Journal · doi:10.1042/bj20150517 · Cited by 291 · see citing works
CHK2 kinase: cancer susceptibility and cancer therapy – two sides of the same coin?
Antoni, L., Sodha, N., Collins, I., & Garrett, M. D. (2007) · Nature reviews. Cancer · doi:10.1038/nrc2251 · Cited by 287 · see citing works
Molecular Pathogenesis of Osteosarcoma
Kansara, M., & Thomas, D. M. (2007) · DNA and Cell Biology · doi:10.1089/dna.2006.0505 · Cited by 273 · see citing works
Mechanism of p53 stabilization by ATM after DNA damage
Cheng, Q., & Chen, J. (2010) · Cell Cycle · doi:10.4161/cc.9.3.10556 · Cited by 248 · see citing works
Self-citationStracker, T. H., Usui, T., & Petrini, J. H. J. (2009) · DNA repair · doi:10.1016/j.dnarep.2009.04.012 · Cited by 245 · see citing works
MDMX overexpression prevents p53 activation by the MDM2 inhibitor Nutlin
Hu, B., Gilkes, D. M., Farooqi, B., Sebti, S. M., & Chen, J. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.c600147200 · Cited by 236 · see citing works
Self-citationMarine, J.-C. W., Dyer, M. A., & Jochemsen, A. G. (2007) · Journal of Cell Science · doi:10.1242/jcs.03362 · Cited by 228 · see citing works
Swift, L. H., & Golsteyn, R. M. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15033403 · Cited by 214 · see citing works
Toledo, F., Krummel, K. A., Lee, C. J., Liu, C.-W., Rodewald, L.-W., Tang, M., & Wahl, G. M. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.03.014 · Cited by 199 · see citing works
CHEK2 Germline Variants in Cancer Predisposition: Stalemate Rather than Checkmate
Stolařová, L., Kleiblová, P., Janatová, M., Soukupová, J., Zemánková, P., Macůrek, L., & Kleibl, Z. (2020) · Cells · doi:10.3390/cells9122675 · Cited by 190 · see citing works
Li, Z., Li, S., Luo, M., Jhong, J.-H., Li, W., Yao, L., Pang, Y., Wang, Z., Wang, R., Ma, R., et al. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab1017 · Cited by 171 · see citing works
An essential function of the extreme C-terminus of MDM2 can be provided by MDMX
Uldrijan, S., Pannekoek, W., & Vousden, K. H. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601469 · Cited by 170 · see citing works
ATM activates p53 by regulating MDM2 oligomerization and E3 processivity
Cheng, Q., Chen, L., Li, Z., Lane, W. S., & Chen, J. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.294 · Cited by 165 · see citing works
Self-citationHdmx modulates the outcome of p53 activation in human tumor cells
Wade, M., Wong, E. T., Tang, M., Stommel, J. M., & Wahl, G. M. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m605405200 · Cited by 163 · see citing works
Activation of the tumor suppressor p53 upon impairment of ribosome biogenesis
Bursać, S., Brdovčak, M. C., Donati, G., & Volarević, S. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.08.014 · Cited by 154 · see citing works
MDMX regulation of p53 response to ribosomal stress
Gilkes, D. M., Chen, L., & Chen, J. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601424 · Cited by 142 · see citing works
Self-citationRegulation of p53: a collaboration between Mdm2 and MdmX
Pei, D., Zhang, Y., & Zheng, J. (2012) · Oncotarget · doi:10.18632/oncotarget.443 · Cited by 140 · see citing works
Pant, V., Xiong, S., Iwakuma, T., Quintás-Cardama, A., & Lozano, G. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1102241108 · Cited by 134 · see citing works
Eukaryotic DNA damage checkpoint activation in response to double-strand breaks
Finn, K., Lowndes, N. F., & Grenon, M. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0875-3 · Cited by 127 · see citing works
Regulation of MDMX nuclear import and degradation by Chk2 and 14-3-3
LeBron, C., Chen, L., Gilkes, D. M., & Chen, J. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601032 · Cited by 122 · see citing works
Self-citationThe multiple checkpoint functions of CHK1 and CHK2 in maintenance of genome stability.
Chen, Y., & Poon, R. Y. C. (2008) · PubMed · doi:10.2741/3060 · Cited by 119 · see citing works
Quantitative analyses reveal the importance of regulated Hdmx degradation for p53 activation
Wang, Y. V., Wade, M., Wong, E., Li, Y.-C., Rodewald, L. W., & Wahl, G. M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701497104 · Cited by 116 · see citing works
MdmX Protein Is Essential for Mdm2 Protein-mediated p53 Polyubiquitination
Wang, X., Wang, J., & Jiang, X. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.213868 · Cited by 115 · see citing works
USP7 Is a Master Regulator of Genome Stability
Valles, G. J., Bezsonova, I., Woodgate, R., & Ashton, N. W. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00717 · Cited by 114 · see citing works
14‐3‐3γ binds to MDMX that is phosphorylated by UV‐activated Chk1, resulting in p53 activation
Jin, Y., Dai, M., Lu, S. Z., Xu, Y., Luo, Z., Zhao, Y., & Lu, H. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601010 · Cited by 113 · see citing works
Anderson, V. E., Walton, M. I., Eve, P. D., Boxall, K. J., Antoni, L., Caldwell, J., Aherne, W., Pearl, L. H., Oliver, A. W., Collins, I., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-1252 · Cited by 112 · see citing works
Mdm2 and MdmX partner to regulate p53
Wang, X., & Jiang, X. (2012) · FEBS Letters · doi:10.1016/j.febslet.2012.02.049 · Cited by 111 · see citing works
Regulation of the p53-MDM2 pathway by 14-3-3 σ and other proteins
Lee, M., & Lozano, G. (2006) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2006.03.009 · Cited by 108 · see citing works
AMP-Activated Protein Kinase Induces p53 by Phosphorylating MDMX and Inhibiting Its Activity
He, G., Zhang, Y.-W., Lee, J., Zeng, S. X., Wang, Y. V., Luo, Z., Dong, X. C., Viollet, B., Wahl, G. M., & Lu, H. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.00670-13 · Cited by 105 · see citing works
Endoplasmic Reticulum Stress, Genome Damage, and Cancer
Dicks, N., Gutierrez, K., Michalak, M., Bordignon, V., & Agellon, L. B. (2015) · Frontiers in Oncology · doi:10.3389/fonc.2015.00011 · Cited by 104 · see citing works
Pellegrino, R., Calvisi, D. F., Neumann, O., Kolluru, V., Wesely, J., Chen, X., Wang, C., Wüestefeld, T., Ladu, S., Elgohary, N., et al. (2013) · Hepatology · doi:10.1002/hep.26954 · Cited by 99 · see citing works
Shibata, S., Arroyo, J. P., Castañeda‐Bueno, M., Puthumana, J., Zhang, J., Uchida, S., Stone, K. L., Lam, T. T., & Lifton, R. P. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1418342111 · Cited by 99 · see citing works
Unleashing the power of p53: lessons from mice and men: Figure 1.Preprint
Poyurovsky, M. V., & Prives, C. L. (2006) · Genes & Development · doi:10.1101/gad.1397506 · Cited by 96 · see citing works
Differential Roles of ATM- and Chk2-Mediated Phosphorylations of Hdmx in Response to DNA Damage
Pereg, Y., Lam, S., Teunisse, A., Biton, S., Meulmeester, E., Mittelman, L., Buscemi, G., Okamoto, K., Taya, Y., Shiloh, Y., et al. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.00562-06 · Cited by 93 · see citing works
Phosphatases in the cellular response to DNA damage
Freeman, A. K., & Monteiro, Á. N. A. (2010) · Cell Communication and Signaling · doi:10.1186/1478-811x-8-27 · Cited by 93 · see citing works
The Regulation of the p53-mediated Stress Response by MDM2 and MDM4Preprint
Perry, M. E. (2009) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a000968 · Cited by 92 · see citing works
Carlessi, L., Buscemi, G., Larson, G., Hong, Z., Wu, J. Z., & Delia, D. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0567 · Cited by 88 · see citing works
Tabe, Y., Sebasigari, D., Jin, L., Rudelius, M., Davies-Hill, T., Miyake, K., Miida, T., Pittaluga, S., & Raffeld, M. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0399 · Cited by 83 · see citing works
Spontaneous Tumorigenesis in Mice Overexpressing the p53-Negative Regulator Mdm4
Xiong, S., Pant, V., Suh, Y.-A., Van Pelt, C. S., Wang, Y., Valentin-Vega, Y. A., Post, S. M., & Lozano, G. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1457 · Cited by 82 · see citing works
Regulation of MDMX Expression by Mitogenic Signaling
Gilkes, D. M., Pan, Y., Coppola, D., Yeatman, T., Reuther, G. W., & Chen, J. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01633-07 · Cited by 82 · see citing works
Self-citationWang, W., Zhang, X., Qin, J., Voruganti, S., Nag, S. A., Wang, M., Wang, H., & Zhang, R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041586 · Cited by 81 · see citing works
MDMX (MDM4), a Promising Target for p53 Reactivation Therapy and BeyondPreprint
Marine, J., & Jochemsen, A. G. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a026237 · Cited by 81 · see citing works
Wang, Y. V., Leblanc, M., Wade, M., Jochemsen, A. G., & Wahl, G. M. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.05.008 · Cited by 79 · see citing works
Phosphorylation of MDMX Mediated by Akt Leads to Stabilization and Induces 14-3-3 Binding
Lopez-Pajares, V., Kim, M. M., & Yuan, Z.-M. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m710030200 · Cited by 79 · see citing works
A p53-independent role for the MDM2 antagonist Nutlin-3 in DNA damage response initiation
Valentine, J. M., Kumar, S., & Moumen, A. (2011) · BMC Cancer · doi:10.1186/1471-2407-11-79 · Cited by 77 · see citing works
Meek, D. W., & Hupp, T. R. (2010) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2009.10.005 · Cited by 76 · see citing works
AlDubayan, S. H., Pyle, L. C., Gamulin, M., Kuliš, T., Moore, N. D., Taylor-Weiner, A. N., Hamid, A., Reardon, B. M., Wubbenhorst, B. S., Godse, R., et al. (2019) · JAMA Oncology · doi:10.1001/jamaoncol.2018.6477 · Cited by 75 · see citing works
Yang, C.-F., Peng, L.-X., Huang, T.-J., Yang, G.-D., Chu, Q.-Q., Liang, Y.-Y., Cao, X., Xie, P., Zheng, L.-S., Huang, H.-B., et al. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.11.006 · Cited by 74 · see citing works
Tabakin-Fix, Y., Azran, I., Schavinsky‐Khrapunsky, Y., Levy, O., & Aboud, M. (2005) · Carcinogenesis · doi:10.1093/carcin/bgi274 · Cited by 72 · see citing works
The versatile functions of ATM kinase
Xu, B., & Boohaker, R. J. (2014) · Biomedical Journal · doi:10.4103/2319-4170.125655 · Cited by 70 · see citing works
Regulation of the Mdm2-p53 signaling axis in the DNA damage response and tumorigenesis
Carr, M. I., & Jones, S. N. (2016) · Translational Cancer Research · doi:10.21037/tcr.2016.11.75 · Cited by 70 · see citing works
Mdmx promotes genomic instability independent of p53 and Mdm2
Carrillo, A. M., Bouska, A., Arrate, M. P., & Eischen, C. M. (2015) · Oncogene · doi:10.1038/onc.2014.27 · Cited by 69 · see citing works
The long and the short of it: the MDM4 tail so far
Haupt, S., Mejía-Hernández, J. O., Vijayakumaran, R., Keam, S. P., & Haupt, Y. (2019) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjz007 · Cited by 69 · see citing works
Inhibition of p53 DNA Binding Function by the MDM2 Protein Acidic Domain
Cross, B. L., Chen, L., Cheng, Q., Li, B., Yuan, Z.-M., & Chen, J. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.228981 · Cited by 69 · see citing works
Self-citationSingh, R. K., Iyappan, S., & Scheffner, M. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m610879200 · Cited by 69 · see citing works
c-Abl Phosphorylates Hdmx and Regulates Its Interaction with p53
Zuckerman, V., Lenos, K., Popowicz, G. M., Silberman, I., Grossman, T., Marine, J.-C., Holak, T. A., Jochemsen, A. G., & Haupt, Y. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m809211200 · Cited by 68 · see citing works
Role of Dietary Antioxidants in p53‐Mediated Cancer Chemoprevention and Tumor Suppression
Merlin, J. P. J., Rupasinghe, H. P. V., Dellaire, G., & Murphy, K. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/9924328 · Cited by 68 · see citing works
Phosphorylation and Degradation of MdmX Is Inhibited by Wip1 Phosphatase in the DNA Damage Response
Zhang, X., Lin, L., Guo, H., Yang, J., Jones, S. N., Jochemsen, A., & Lu, X. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0634 · Cited by 67 · see citing works
Berberine, a genotoxic alkaloid, induces ATM-Chk1 mediated G2 arrest in prostate cancer cells
Wang, Y., Liu, Q., Liu, Z., Li, B., Sun, Z.-L., Zhou, H., Zhang, X., Gong, Y., & Shao, C. (2012) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2012.04.005 · Cited by 66 · see citing works
Zhao, H. L., Traganos, F., & Darżynkiewicz, Z. (2008) · Cell Cycle · doi:10.4161/cc.7.19.6750 · Cited by 65 · see citing works
Regulation of the Life Cycle of HPVs by Differentiation and the DNA Damage Response
Hong, S., & Laimins, L. A. (2013) · Future Microbiology · doi:10.2217/fmb.13.127 · Cited by 62 · see citing works
The p53-mediated cytotoxicity of photodynamic therapy of cancer: Recent advances
Zawacka‐Pankau, J., Krachulec, J., Grulkowski, I., Bielawski, K. P., & Selivanova, G. (2008) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2008.07.012 · Cited by 59 · see citing works
Deep, G., Oberlies, N. H., Kroll, D. J., & Agarwal, R. (2008) · Oncogene · doi:10.1038/onc.2008.45 · Cited by 59 · see citing works
Xu, Q., Li, M., Yang, M., Yang, J., Xie, J., Lu, X., Wang, F., & Chen, W. (2018) · Bioscience Reports · doi:10.1042/bsr20180980 · Cited by 59 · see citing works
Essack, M., Bajić, V. B., & Archer, J. A. C. (2011) · Marine Drugs · doi:10.3390/md9091580 · Cited by 58 · see citing works
Identification and characterisation of 2-aminopyridine inhibitors of checkpoint kinase 2
Hilton, S. T., Naud, S., Caldwell, J., Boxall, K. J., Burns, S., Anderson, V. E., Antoni, L., Allen, C. E., Pearl, L. H., Oliver, A. W., et al. (2009) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2009.11.058 · Cited by 57 · see citing works
Phillips, A., Teunisse, A., Lam, S., Lodder, K., Darley, M., Emaduddin, M., Wolf, A., Richter, J., de Lange, J., Verlaan-de Vries, M., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.129726 · Cited by 55 · see citing works
Deubiquitinating enzyme regulation of the p53 pathway: A lesson from Otub1
Sun, X. (2014) · World Journal of Biological Chemistry · doi:10.4331/wjbc.v5.i2.75 · Cited by 55 · see citing works
The role of DNA damage and repair in atherosclerosis: A review
Shah, N. R., & Mahmoudi, M. (2015) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2015.07.005 · Cited by 55 · see citing works
HDMX Folds the Nascent p53 mRNA following Activation by the ATM Kinase
Malbert-Colas, L., Ponnuswamy, A., Olivares‐Illana, V., Tournillon, A.-S., Naski, N., & Fåhræus, R. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.02.035 · Cited by 55 · see citing works
Sato, Y., Shirata, N., Kudoh, A., Iwahori, S., Nakayama, S., Murata, T., Isomura, H., Nishiyama, Y., & Tsurumi, T. (2009) · Virology · doi:10.1016/j.virol.2009.03.017 · Cited by 55 · see citing works
Sarkari, F., La Delfa, A., Arrowsmith, C. H., Frappier, L., Sheng, Y., & Saridakis, V. (2010) · Journal of Molecular Biology · doi:10.1016/j.jmb.2010.08.017 · Cited by 54 · see citing works
Kim, J., Keay, S. K., Dimitrakov, J. D., & Freeman, M. R. (2007) · FEBS Letters · doi:10.1016/j.febslet.2007.06.058 · Cited by 52 · see citing works
A single synonymous mutation determines the phosphorylation and stability of the nascent protein
Karakostis, K., Gnanasundram, S. V., López, I., Thermou, A., Wang, L., Nylander, K., Olivares‐Illana, V., & Fåhræus, R. (2018) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjy049 · Cited by 52 · see citing works
Secondary interaction between MDMX and p53 core domain inhibits p53 DNA binding.
Wei, X., Wu, S., Song, T., Chen, L., Gao, M., Borcherds, W., Daughdrill, G. W., & Chen, J. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1603838113 · Cited by 50 · see citing works
Self-citationp53 regulation: Teamwork between RING domains of Mdm2 and MdmX
Wang, X. (2011) · Cell Cycle · doi:10.4161/cc.10.24.18662 · Cited by 50 · see citing works
The Intersection of DNA Damage Response and Ferroptosis—A Rationale for Combination Therapeutics
Chen, P.-H., Tseng, W. H.-S., & Chi, J. (2020) · Biology · doi:10.3390/biology9080187 · Cited by 51 · see citing works
Autoinhibition of MDMX by intramolecular p53 mimicry
Chen, L., Borcherds, W. M., Wu, S., Becker, A., Schönbrunn, E., Daughdrill, G. W., & Chen, J. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1420833112 · Cited by 49 · see citing works
Self-citationRegulation of MDM2 Stability After DNA Damage
Li, J., & Kurokawa, M. (2015) · Journal of Cellular Physiology · doi:10.1002/jcp.24994 · Cited by 48 · see citing works
Boosting Natural Killer Cell-Based Immunotherapy with Anticancer Drugs: a Perspective
Cifaldi, L., Locatelli, F., Marasco, E., Moretta, L., & Pistoia, V. (2017) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2017.10.002 · Cited by 48 · see citing works
Casein Kinase 1α Regulates an MDMX Intramolecular Interaction To Stimulate p53 Binding
Wu, S., Chen, L., Becker, A., Schönbrunn, E., & Chen, J. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.00851-12 · Cited by 48 · see citing works
Self-citationMDM2, MDMX, and p73 regulate cell-cycle progression in the absence of wild-type p53
Klein, A. M., Biderman, L., Tong, D., Alaghebandan, B., Plumber, S. A., Mueller, H. S., van Vlimmeren, A. E., Katz, C., & Prives, C. L. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2102420118 · Cited by 47 · see citing works
Cancer Vulnerabilities Through Targeting the ATR/Chk1 and ATM/Chk2 Axes in the Context of DNA Damage
Fernandez, A., Artola, M., Leon, S., Otegui, N., Jimeno, A., Serrano, D., & Calvo, A. (2025) · Cells · doi:10.3390/cells14100748 · Cited by 45 · see citing works
DNA Damage-Induced Cell Cycle Regulation and Function of Novel Chk2 Phosphoresidues
Buscemi, G., Carlessi, L., Zannini, L., Lisanti, S., Fontanella, E., Canevari, S., & Delia, D. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.00534-06 · Cited by 44 · see citing works
Regulation of Chk2 Ubiquitination and Signaling through Autophosphorylation of Serine 379
Lovly, C. M., Yan, L., Ryan, C. E., Takada, S., & Piwnica-Worms, H. M. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.00821-08 · Cited by 43 · see citing works
The Role of MDM2 in Promoting Genome Stability versus Instability
Saadatzadeh, M. R., Elmi, A. N., Pandya, P. H., Bijangi‐Vishehsaraei, K., Ding, J., Stamatkin, C. W., Cohen‐Gadol, A., & Pollok, K. E. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18102216 · Cited by 43 · see citing works
Mancini, F. R., Pieroni, L., Monteleone, V., Lucà, R., Fici, L., Luca, E., Urbani, A., Xiong, S., Soddu, S., Masetti, R., et al. (2015) · Oncogene · doi:10.1038/onc.2015.76 · Cited by 42 · see citing works
Spinnler, C., Hedström, E., Li, H., de Lange, J., Nikulenkov, F., Teunisse, A. F. A. S., Vries, M. V., Grinkevich, V. V., Jochemsen, A. G., & Selivanova, G. (2011) · Cell Death and Differentiation · doi:10.1038/cdd.2011.45 · Cited by 42 · see citing works
- Authors
- Chen, L., Gilkes, D. M., Pan, Y., Lane, W. S., & Chen, J.
- Affiliations
- Moffitt Cancer Center (US)
- Harvard University (US)
- Corresponding author
- Chen, Jiandong
- Venue
- The EMBO Journal
- Published
- 2005-09-15
- Volume
- 24
- Issue
- 19
- Pages
- 3411-3422
- ISSN
- 0261-4189 (ISSN-L)
- 1460-2075
- PMC
- PMC1276172
- OpenAlex
- W2116326380
- Semantic Scholar
- 74f10c564d416135fbbc705c0184d57a01fc3e2a
- Cited by
- 260
- References
- 43
- Citations by year
- 2026: 5 · 2025: 4 · 2024: 8 · 2023: 2 · 2022: 8 · 2021: 10 · 2020: 10 · 2019: 8 · 2018: 10 · 2017: 9 · 2016: 17 · 2015: 17 · 2014: 15 · 2013: 20 · 2012: 20
- FWCI
- 6.41
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- The EMBO Journal (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- American Cancer Society
- National Institutes of Health
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Keywords
- p53 activation, MDMX, MDM2, ATM kinase, Chk2, DNA damage response, protein phosphorylation, ubiquitination, protein degradation, ionizing radiation, E3 ubiquitin ligase, tumor suppressor
- MeSH terms
- Cells, Cultured, Chromatography, High Pressure Liquid, DNA Damage, DNA-Binding Proteins, Electrophoresis, Polyacrylamide Gel, Gene Expression Regulation, Humans, Nuclear Proteins, Phosphorylation, Proto-Oncogene Proteins, Mass Spectrometry, Blotting, Western, Tumor Suppressor Protein p53, Protein Serine-Threonine Kinases, Cell Cycle Proteins, Tumor Suppressor Proteins, RNA Interference, RNA, Small Interfering, Immunoprecipitation, Proto-Oncogene Proteins c-mdm2, Ataxia Telangiectasia Mutated Proteins, Checkpoint Kinase 2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-08.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-08.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review